KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Assets Average (2016 - 2025)

Historic Assets Average for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to $4.0 billion.

  • West Pharmaceutical Services' Assets Average rose 1247.96% to $4.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 billion, marking a year-over-year increase of 1247.96%. This contributed to the annual value of $3.7 billion for FY2024, which is 35.72% up from last year.
  • As of Q3 2025, West Pharmaceutical Services' Assets Average stood at $4.0 billion, which was up 1247.96% from $3.8 billion recorded in Q2 2025.
  • In the past 5 years, West Pharmaceutical Services' Assets Average ranged from a high of $4.0 billion in Q3 2025 and a low of $2.8 billion during Q1 2021
  • Moreover, its 5-year median value for Assets Average was $3.6 billion (2024), whereas its average is $3.5 billion.
  • As far as peak fluctuations go, West Pharmaceutical Services' Assets Average soared by 2229.89% in 2021, and later plummeted by 407.81% in 2024.
  • Over the past 5 years, West Pharmaceutical Services' Assets Average (Quarter) stood at $3.2 billion in 2021, then increased by 7.39% to $3.5 billion in 2022, then increased by 9.38% to $3.8 billion in 2023, then fell by 3.5% to $3.7 billion in 2024, then increased by 10.11% to $4.0 billion in 2025.
  • Its last three reported values are $4.0 billion in Q3 2025, $3.8 billion for Q2 2025, and $3.6 billion during Q1 2025.